Thinking up tomorrow's medicine
A new member joins Atlanpole Biotherapies cluster: Bioprédic International, a provider of research reagents
BIOPREDIC International, a supplier of reagents serving the academic and private research, has joined the cluster. BIOPREDIC International is an SME of 25 employees based in St Gregoire (in the department of Ille et Vilaine), with a subsidiary in the United States and a worldwide network of distributors. Through the network of Atlanpole Biotherapies, Bioprédic International wishes to increase the rate of its development by participating in innovative projects, proceeding from academic and private professionals in the field of health, chemistry and well-being.
Evaluation agreement with Institut Pasteur to validate ICANtibodies™ as an alternative platform technology to discover antibodies
[Press release] In-Cell-Art, a biotechnology company specializing in nanocarrier technologies called Nanotaxi® for macromolecules delivery (DNA, RNA, Protein), announces the evaluation agreement with Institut Pasteur to validate ICANtibodies(TM), a fully integrated antibodies discovery process without peptide and recombinant protein (from plasmid DNA antigen design and synthesis, Nanotaxi®/plasmid formulation and immunization in various species, to antibody quality controls) as an alternative platform technology to discover antibodies against challenging targets.
12 companies or research platforms from our cluster will be present on a collective booth during the european biotech event, Bio Europe SPring, in Turin, from 10th to 12nd of march.
How to prepare the inoculum for seeding bioreactors whilst conforming to GMP guidelines ? Training dedicated to technicians with concepts in biotechnology and delivered by Biopractis training center en Nantes, France.
This two-day international workshop features presenta¬tions by leading actors in the field of anti-tumor immunity from academia, industry and biotech companies providing a platform for scientific discussion and launching of colla-borative projects.
The Stern-Forum: "Innovation and Biomaterials" serves as a pathfinder for entrepreneurs and researchers in order to establish upcoming business contacts and collaborations. The event, which will be held in English, is organised in the context of the two EU-projects, nameley Biomat-IN and IN2LifeSciences. This will afford you the opportunity to engage with regional biotechnology, medical technology and other life sciences companies.
International Cancer Cluster Showcase will take place June 22nd, 2014 - Bio San Diego
Organised by the European Orthopaedic Research Society, the EORS 2014 meeting will focus on the following special topics: the mechanisms of osteoinduction, osteoimmunology and bone tumors, transferring innovation to clinical practice. 300 people are expected at this conference that offers workshops and presentations by renowned researchers and surgeons.
The Atlanpole Biotherapies competitive cluster combines the expertise of laboratories, companies and technical departments for a public-private offer of services, comprehensive, relevant and competitive, in the value chain of bio-medicine from target discovery to clinical evaluation.
Our ambition is to become a reference center on an international scale for the development of diagnostic and therapeutic solutions in the field of biotherapies.
Atlanpole Biotherapies is a competitive cluster certified by the Ministry of Industry (July 2005).